SCHEMBL2652470

SCHEMBL2652470

COCCOC(=O)c1ccc(Nc2cccc(N3CCN(C)CC3)c2)c(N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
HTR2A P28223 1/20 0.45
NPC1 O15118 2/20 0.44
PTGER4 P35408 2/20 0.44
GAA P10253 1/20 0.44
GFER P55789 1/20 0.44
HDAC3 O15379 2/20 0.44
HDAC8 Q9BY41 1/20 0.44
CCNT1 O60563 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CDK9 P50750 1/20 0.41
CDK6 Q00534 1/20 0.41
CDK11A Q9UQ88 1/20 0.41
HDAC1 Q13547 1/20 0.41
HTR6 P50406 2/20 0.41
CDC25B P30305 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2662043 0.92 HTR1D (0.44) HTR1DHTR1BHTR2ANPC1PTGER4
SCHEMBL2651673 0.91 PTGER4 (0.45) NPC1PTGER4GAAGFERCDC25B
SCHEMBL2653592 0.91 MAPT (0.43) NPC1PTGER4GAAGFERCCNT1
SCHEMBL2651242 0.89 TSHR (0.43) NPC1PTGER4GAAGFERCDC25B
SCHEMBL2662153 0.89 GAA (0.44) NPC1PTGER4GAAGFERALDH1A1
SCHEMBL2650857 0.89 TSHR (0.43) NPC1PTGER4GAAGFERALDH1A1
SCHEMBL2652432 0.89 HTR1D (0.41) HTR1DHTR1BHTR2ANPC1PTGER4
SCHEMBL4698910 0.88 HTR4 (0.46) NPC1PTGER4GAAGFERMAPT
SCHEMBL2661919 0.88 NPC1 (0.41) NPC1PTGER4GAAGFERCDC25B
SCHEMBL2651430 0.88 PTGER4 (0.43) NPC1PTGER4GAAGFERCDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194410-B1 BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THESE COMPOUNDS NEUROSEARCH AS (DK) 2006-01-18 EP disclosed
US-6936613-B2 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds NEUROSEARCH A/S (DK) 2005-08-30 US disclosed
US-20040097570-A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds NEUROSEARCH A/S 2004-05-20 US disclosed
US-6649609-B2 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children NEUROSEARCH A/S (DK) 2003-11-18 US disclosed
US-20030055055-A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds ANIONA APS (DK) 2003-03-20 US disclosed
EP-1194410-A1 BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THESE COMPOUNDS NEUROSEARCH A/S (DK) 2002-04-10 EP disclosed
WO-2000078728-A1 NOVEL BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THESE COMPOUNDS NEUROSEARCH A/S (DK) 2000-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097570-A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds GABRA1, GABRA2, GABRA4 HTR1D 1776/4885HTR1B 1557/4885HTR2A 1798/4885
US-20030055055-A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds GABRA1, GABRA2, GABRA4 HTR1D 1736/4885HTR1B 1492/4885HTR2A 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.